Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma.

Saved in:

Bibliographic Details
Title:	Corrigendum: Immune Response Generated With the Administration of Autologous Dendritic Cells Pulsed With an Allogenic Tumoral Cell-Lines Lysate in Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma.
Authors:	Benitez-Ribas D; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain., Cabezón R; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain., Flórez-Grau G; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain., Molero MC; Department of Clinical Trials, Hospital Sant Joan de Déu, Barcelona, Spain., Puerta P; Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain., Guillen A; Department of Neurosurgery, Hospital Sant Joan de Déu, Barcelona, Spain., González-Navarro EA; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain., Paco S; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Carcaboso AM; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Santa-Maria Lopez V; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Cruz O; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., de Torres C; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Salvador N; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Juan M; Department of Immunology, Hospital Clinic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain.; Department of Immunotherapy, Hospital Sant Joan de Déu, Barcelona, Spain., Mora J; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain., Morales La Madrid A; Laboratory of Developmental Cancer, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Department of Oncology and Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.; Department of Neuro-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.
Source:	Frontiers in oncology [Front Oncol] 2018 Jun 05; Vol. 8, pp. 201. Date of Electronic Publication: 2018 Jun 05 (Print Publication: 2018).
Publication Type:	Journal Article; Published Erratum
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2234-943X
DOI:	10.3389/fonc.2018.00201